Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02126579 |
| Title | Phase I/II Trial of a Long Peptide Vaccine (LPV7) Plus TLR Agonists |
| Acronym | MEL60 |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Craig L Slingluff, Jr |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |